Department of Medicine and Surgery, Anatomy Unit, University of Parma, 43126 Parma, Italy.
University Hospital of Parma, AOU-PR, 43126 Parma, Italy.
Cells. 2021 Sep 29;10(10):2597. doi: 10.3390/cells10102597.
Myeloproliferative neoplasms are hematologic malignancies typified by a substantial heritable component. Germline variants may affect the risk of developing a MPN, as documented by GWAS studies on large patient cohorts. In addition, once the MPN occurred, inherited host genetic factors can be responsible for tuning the disease phenotypic presentation, outcome, and response to therapy. This review covered the polymorphisms that have been variably associated to MPNs, discussing them in the functional perspective of the biological pathways involved. Finally, we reviewed host genetic determinants of clonal hematopoiesis, a pre-malignant state that may anticipate overt hematologic neoplasms including MPNs.
骨髓增生性肿瘤是一类血液系统恶性肿瘤,其特征是具有相当大的遗传性成分。胚系变异可能会影响 MPN 的发病风险,这一点已被针对大型患者队列的 GWAS 研究所证实。此外,一旦 MPN 发生,遗传宿主遗传因素可能会负责调整疾病的表型表现、结局和对治疗的反应。本综述涵盖了与 MPN 相关的各种多态性,从涉及的生物学途径的功能角度对它们进行了讨论。最后,我们回顾了克隆性造血的宿主遗传决定因素,这是一种可能预示着显性血液系统肿瘤(包括 MPN)的前恶性状态。